EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS

<p><em>This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral densit...

Full description

Bibliographic Details
Main Authors: A.O. Lisitsyn, E.I. Alexeeva, V.G. Pinelis, M.I. Bakanov, S.I. Valieva, T.M. Bzarova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/835
_version_ 1827882714022281216
author A.O. Lisitsyn
E.I. Alexeeva
V.G. Pinelis
M.I. Bakanov
S.I. Valieva
T.M. Bzarova
author_facet A.O. Lisitsyn
E.I. Alexeeva
V.G. Pinelis
M.I. Bakanov
S.I. Valieva
T.M. Bzarova
author_sort A.O. Lisitsyn
collection DOAJ
description <p><em>This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral density of bones, decrease of pain intensity, lessening of serum concentration of bone resorption marker — C-terminal telopeptide. The development of repeated compressive fractures of vertebrae and bones of peripheral skeleton at the time of treatment with this medication was not detected. </em><strong><em></em></strong></p><p><strong><em>Key words: children, rheumatological diseases, osteoporosis, treatment, bifosfonates, ibandronic acid.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2010;9(1):116-121)</em></span></p>
first_indexed 2024-03-12T19:01:39Z
format Article
id doaj.art-c91e9f067cba44f68aa7d6d5a3887529
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T19:01:39Z
publishDate 2010-01-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-c91e9f067cba44f68aa7d6d5a38875292023-08-02T06:38:46Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352010-01-0191116121835EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSISA.O. Lisitsyn0E.I. Alexeeva1V.G. Pinelis2M.I. Bakanov3S.I. Valieva4T.M. Bzarova5Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow<p><em>This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral density of bones, decrease of pain intensity, lessening of serum concentration of bone resorption marker — C-terminal telopeptide. The development of repeated compressive fractures of vertebrae and bones of peripheral skeleton at the time of treatment with this medication was not detected. </em><strong><em></em></strong></p><p><strong><em>Key words: children, rheumatological diseases, osteoporosis, treatment, bifosfonates, ibandronic acid.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2010;9(1):116-121)</em></span></p>http://vsp.spr-journal.ru:80/jour/article/view/835
spellingShingle A.O. Lisitsyn
E.I. Alexeeva
V.G. Pinelis
M.I. Bakanov
S.I. Valieva
T.M. Bzarova
EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
Вопросы современной педиатрии
title EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
title_full EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
title_fullStr EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
title_full_unstemmed EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
title_short EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
title_sort experience of treatment with ibandronic acid in patients with severe rheumatological diseases and systemic osteoporosis
url http://vsp.spr-journal.ru:80/jour/article/view/835
work_keys_str_mv AT aolisitsyn experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis
AT eialexeeva experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis
AT vgpinelis experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis
AT mibakanov experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis
AT sivalieva experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis
AT tmbzarova experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis